| Primary |
| Product Used For Unknown Indication |
72.2% |
| Cardiovascular Event Prophylaxis |
11.1% |
| Prostatic Adenoma |
11.1% |
| Oedema Peripheral |
5.6% |
|
| Renal Failure |
50.0% |
| Urinary Retention |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
38.3% |
| Congestive Cardiomyopathy |
12.1% |
| Hypertension |
8.4% |
| Dementia Alzheimer's Type |
5.8% |
| Dyslipidaemia |
5.0% |
| Ischaemic Cardiomyopathy |
4.7% |
| Prophylaxis |
3.2% |
| Anxiety |
2.9% |
| Atrial Fibrillation |
2.6% |
| Drug Use For Unknown Indication |
2.6% |
| Cardiorenal Syndrome |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Bronchitis |
1.8% |
| Myocardial Ischaemia |
1.8% |
| Coronary Artery Insufficiency |
1.6% |
| Angina Pectoris |
1.1% |
| Superinfection |
1.1% |
| Tremor |
1.1% |
| Cardiovascular Event Prophylaxis |
0.8% |
| Lung Infection |
0.8% |
|
| Hyperhidrosis |
16.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
9.3% |
| Tricuspid Valve Disease |
9.3% |
| Oedema |
7.4% |
| Pulmonary Embolism |
7.4% |
| Renal Failure |
5.6% |
| Toxic Skin Eruption |
5.6% |
| Dementia Alzheimer's Type |
3.7% |
| Hyponatraemia |
3.7% |
| Hypotension |
3.7% |
| Intentional Overdose |
3.7% |
| Lichenoid Keratosis |
3.7% |
| Malaise |
3.7% |
| Pneumoperitoneum |
3.7% |
| Subdural Haematoma |
3.7% |
| Accidental Drug Intake By Child |
1.9% |
| Anaemia |
1.9% |
| Angina Pectoris |
1.9% |
| Anxiety |
1.9% |
| Aortic Valve Disease |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.4% |
| Product Used For Unknown Indication |
22.7% |
| Hypertension |
10.3% |
| Angina Pectoris |
4.7% |
| Colon Cancer |
3.7% |
| Hiv Infection |
3.4% |
| Type 2 Diabetes Mellitus |
3.3% |
| Atrial Fibrillation |
3.1% |
| Myocardial Ischaemia |
2.9% |
| Ill-defined Disorder |
2.5% |
| Parkinson's Disease |
1.8% |
| Pain |
1.7% |
| Diffuse Large B-cell Lymphoma Recurrent |
1.6% |
| Depression |
1.5% |
| Hypercholesterolaemia |
1.3% |
| Dementia Alzheimer's Type |
1.2% |
| Diabetes Mellitus |
1.2% |
| Diarrhoea |
1.2% |
| Diffuse Large B-cell Lymphoma |
1.2% |
| Mitochondrial Toxicity |
1.2% |
|
| Renal Failure Acute |
12.6% |
| Myocardial Infarction |
6.7% |
| Thrombocytopenia |
6.7% |
| Fall |
5.9% |
| Hyponatraemia |
5.9% |
| Somnolence |
5.9% |
| Acute Respiratory Distress Syndrome |
5.0% |
| Peripheral Sensory Neuropathy |
5.0% |
| Rhabdomyolysis |
5.0% |
| Vomiting |
5.0% |
| Angioedema |
4.2% |
| Malaise |
4.2% |
| Tachypnoea |
4.2% |
| International Normalised Ratio Increased |
3.4% |
| Pyrexia |
3.4% |
| Renal Failure |
3.4% |
| Status Epilepticus |
3.4% |
| Thrombosis |
3.4% |
| Ventricular Extrasystoles |
3.4% |
| Weight Decreased |
3.4% |
|
